Ryancoates (Talk | contribs) |
Ryancoates (Talk | contribs) |
||
Line 25: | Line 25: | ||
<td>pGB-A2</td> | <td>pGB-A2</td> | ||
<td>A constitutive promoter with our TSH antagonist <b>without</b> the his tags for purification</td> | <td>A constitutive promoter with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 32: | Line 33: | ||
<td>pGB-A2</td> | <td>pGB-A2</td> | ||
<td>A constitutive promoter with our TSH antagonist <b>with</b> the his tags for purification</td> | <td>A constitutive promoter with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 39: | Line 41: | ||
<td>pGB-A2</td> | <td>pGB-A2</td> | ||
<td>A constitutive promoter with Luc+ as a coding sequence to analyse expression levels</td> | <td>A constitutive promoter with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 45: | Line 48: | ||
<td>NosT</td> | <td>NosT</td> | ||
<td>pGB-A2</td> | <td>pGB-A2</td> | ||
+ | <td>A constitutive promoter with Lucx5 as a coding sequence to analyse expression levels. This variant is heat resistant</td> | ||
+ | <td>~length</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 51: | Line 56: | ||
<td>NosT</td> | <td>NosT</td> | ||
<td>pGB-A2</td> | <td>pGB-A2</td> | ||
+ | <td>A constitutive promoter with XVE as a coding sequence. This produces a protein product that activates the inducible promoter LexA</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>LexA</td> | ||
+ | <td>TSH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter that is induced by XVE with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>LexA</td> | ||
+ | <td>TSHH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter that is induced by XVE with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>LexA</td> | ||
+ | <td>Luc+</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter that is induced by XVE with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>LexA</td> | ||
+ | <td>Lucx5</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter that is induced by XVE with Lucx5 as a coding sequence to analyse expression levels. This variant is heat resistant</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PDF1</td> | ||
+ | <td>TSH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by jasmonic acid with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PDF1</td> | ||
+ | <td>TSHH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by jasmonic acid with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PDF1</td> | ||
+ | <td>Luc+</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by jasmonic acid with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PR2</td> | ||
+ | <td>TSH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by salicylic acid with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PR2</td> | ||
+ | <td>TSHH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by salicylic acid with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>PR2</td> | ||
+ | <td>Luc+</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by salicylic acid with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>GST6</td> | ||
+ | <td>TSH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by salicylic acid with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>GST6</td> | ||
+ | <td>TSHH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by salicylic acid with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>WRKY30</td> | ||
+ | <td>Luc+</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by the presence of cellulose (DAMP response) with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>WRKY30</td> | ||
+ | <td>TSH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by the presence of cellulose (DAMP response) with our TSH antagonist <b>without</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>WRKY30</td> | ||
+ | <td>TSHH</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by the presence of cellulose (DAMP response) with our TSH antagonist <b>with</b> the his tags for purification</td> | ||
+ | <td>~length</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>WRKY30</td> | ||
+ | <td>Luc+</td> | ||
+ | <td>NosT</td> | ||
+ | <td>pGB-A2</td> | ||
+ | <td>A promoter induced by the presence of cellulose (DAMP response) with Luc+ as a coding sequence to analyse expression levels</td> | ||
+ | <td>~length</td> | ||
</tr> | </tr> | ||
</table> | </table> |
Revision as of 19:54, 2 September 2017